This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Aalberse RC, van der Gaag R, van Leeuwen J (1983) Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol 130:722–726. https://doi.org/10.4049/jimmunol.130.2.722AalberseRCvan der GaagRvan LeeuwenJ1983Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response130722726https://doi.org/10.4049/jimmunol.130.2.722Search in Google Scholar
Bartalena L, Kahaly GJ, Baldeschi L et al (2021) The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy. Eur J Endocrinol 185:G43–G67. https://doi.org/10.1530/EJE-21-0479BartalenaLKahalyGJBaldeschiL2021The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy185G43G67https://doi.org/10.1530/EJE-21-0479Search in Google Scholar
Bozkirli E, Bakiner OS, Ersozlu Bozkirli ED et al (2015) Serum immunoglobulin G4 levels are elevated in patients with Graves’ ophthalmopathy. Clin Endocrinol 83:962–967. https://doi.org/10.1111/cen.12671BozkirliEBakinerOSErsozlu BozkirliED2015Serum immunoglobulin G4 levels are elevated in patients with Graves’ ophthalmopathy83962967https://doi.org/10.1111/cen.12671Search in Google Scholar
Comi S, Lanzolla G, Cosentino G et al (2023) IgG4 serum levels in Graves’ orbitopathy. J Endocrinol Invest 47, 1711–1717. https://doi.org/10.1007/s40618-023-02265-3ComiSLanzollaGCosentinoG2023IgG4 serum levels in Graves’ orbitopathy4717111717https://doi.org/10.1007/s40618-023-02265-3Search in Google Scholar
Ebbo M, Grados A, Bernit E et al (2012) Pathologies associated with serum IgG4 elevation. Int J Rheumatol 2012:602809. https://doi.org/10.1155/2012/602809EbboMGradosABernitE2012Pathologies associated with serum IgG4 elevation2012602809https://doi.org/10.1155/2012/602809Search in Google Scholar
Elshaer RK, Halawa MR, Ahmed IZ et al (2022) Serum IgG4 level for malignancy prediction in indeterminate thyroid nodules among patients with or without autoimmune thyroid disease. Egypt J Immunol 29:156–162.ElshaerRKHalawaMRAhmedIZ2022Serum IgG4 level for malignancy prediction in indeterminate thyroid nodules among patients with or without autoimmune thyroid disease29156162Search in Google Scholar
Hiratsuka I, Yamada H, Itoh M et al (2020) Changes in serum immunoglobulin G4 levels in patients with newly diagnosed Graves’ disease. Exp Clin Endocrinol Diabetes 128:119–124. https://doi.org/10.1055/a-0669-9333HiratsukaIYamadaHItohM2020Changes in serum immunoglobulin G4 levels in patients with newly diagnosed Graves’ disease128119124https://doi.org/10.1055/a-0669-9333Search in Google Scholar
Kamisawa T, Funata N, Hayashi Y et al (2003) A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 38:982–984. https://doi.org/10.1007/s00535-003-1175-yKamisawaTFunataNHayashiY2003A new clinicopathological entity of IgG4-related autoimmune disease38982984https://doi.org/10.1007/s00535-003-1175-ySearch in Google Scholar
Katz G, Stone JH (2022) Clinical perspectives on IgG4-related disease and its classification. Annu Rev Med 73:545–562. https://doi.org/10.1146/annurev-med-050219-034449KatzGStoneJH2022Clinical perspectives on IgG4-related disease and its classification73545562https://doi.org/10.1146/annurev-med-050219-034449Search in Google Scholar
Koneczny I, Tzartos J, Mané-Damas M et al (2022) IgG4 autoantibodies in organ-specific autoimmunopathies: Reviewing class switching, antibody-producing cells, and specific immunotherapies. Front Immunol 13:834342. https://doi.org/10.3389/fimmu.2022.834342KonecznyITzartosJMané-DamasM2022IgG4 autoantibodies in organ-specific autoimmunopathies: Reviewing class switching, antibody-producing cells, and specific immunotherapies13834342https://doi.org/10.3389/fimmu.2022.834342Search in Google Scholar
Kottahachchi D, Topliss DJ (2016) Immunoglobulin G4-related thyroid diseases. Eur Thyroid J 5:231–239. https://doi.org/10.1159/000452623KottahachchiDToplissDJ2016Immunoglobulin G4-related thyroid diseases5231239https://doi.org/10.1159/000452623Search in Google Scholar
Lang D, Zwerina J, Pieringer H (2016) IgG4-related disease: Current challenges and future prospects. Ther Clin Risk Manag 12: 189–199. https://doi.org/10.2147/TCRM.S99985LangDZwerinaJPieringerH2016IgG4-related disease: Current challenges and future prospects12189199https://doi.org/10.2147/TCRM.S99985Search in Google Scholar
Li Y, Luo B, Zhang J et al (2021) Clinical relevance of serum immunoglobulin G4 in glucocorticoid therapy of Graves’ ophthalmopathy. Clin Endocrinol 95:657–667. https://doi.org/10.1111/cen.14493LiYLuoBZhangJ2021Clinical relevance of serum immunoglobulin G4 in glucocorticoid therapy of Graves’ ophthalmopathy95657667https://doi.org/10.1111/cen.14493Search in Google Scholar
Luo B, Yuan X, Wang W et al (2022) Ocular manifestations and clinical implications of serum immunoglobulin G4 levels in Graves’ ophthalmopathy patients. Ocul Immunol Inflamm 30:580–587. https://doi.org/10.1080/09273948.2020.1826537LuoBYuanXWangW2022Ocular manifestations and clinical implications of serum immunoglobulin G4 levels in Graves’ ophthalmopathy patients30580587https://doi.org/10.1080/09273948.2020.1826537Search in Google Scholar
Martin CS, Sirbu AE, Betivoiu MA et al (2017) Serum immunoglobulin G4 levels and Graves’ disease phenotype. Endocrine 55: 478–484. https://doi.org/10.1007/s12020-016-1157-5MartinCSSirbuAEBetivoiuMA2017Serum immunoglobulin G4 levels and Graves’ disease phenotype55478484https://doi.org/10.1007/s12020-016-1157-5Search in Google Scholar
Nowak M, Nowak W, Marek B et al (2024) Differential diagnosis of thyroid orbitopathy — diseases mimicking the presentation or activity of thyroid orbitopathy. Endokrynol Pol 75:1–11. https://doi.org/10.5603/ep.98156NowakMNowakWMarekB2024Differential diagnosis of thyroid orbitopathy — diseases mimicking the presentation or activity of thyroid orbitopathy75111https://doi.org/10.5603/ep.98156Search in Google Scholar
Olejarz M, Szczepanek-Parulska E, Dadej D et al (2021) IgG4 as a biomarker in graves’ orbitopathy. Mediators Inflamm 10:2021:5590471. https://doi.org/10.1155/2021/5590471OlejarzMSzczepanek-ParulskaEDadejD2021IgG4 as a biomarker in graves’ orbitopathy1020215590471https://doi.org/10.1155/2021/5590471Search in Google Scholar
Olejarz M, Szczepanek-Parulska E, Ostałowska-Klockiewicz A et al (2023) High IgG4 serum concentration is associated with active Graves orbitopathy. Front Endocrinol 14:1083321. https://doi.org/10.3389/fendo.2023.1083321OlejarzMSzczepanek-ParulskaEOstałowska-KlockiewiczA2023High IgG4 serum concentration is associated with active Graves orbitopathy141083321https://doi.org/10.3389/fendo.2023.1083321Search in Google Scholar
Rotondi M, Carbone A, Coperchini F et al (2019) Diagnosis of endocrine disease: IgG4-related thyroid autoimmune disease. Eur J Endocrinol 180:R175–R183. https://doi.org/10.1530/EJE-18-1024RotondiMCarboneACoperchiniF2019Diagnosis of endocrine disease: IgG4-related thyroid autoimmune disease180R175R183https://doi.org/10.1530/EJE-18-1024Search in Google Scholar
Sawicka-Gutaj N, Gruszczyński D, Guzik P et al (2022) Publication ethics of human studies in the light of the Declaration of Helsinki – a mini-review. J Med Sci 91:e700. https://doi.org/10.20883/medical.e700Sawicka-GutajNGruszczyńskiDGuzikP2022Publication ethics of human studies in the light of the Declaration of Helsinki – a mini-review91e700https://doi.org/10.20883/medical.e700Search in Google Scholar
Sy A, Silkiss RZ (2016) Serum total IgG and IgG4 levels in thyroid eye disease. Int Med Case Rep J 9:325–328. https://doi.org/10.2147/IMCRJ.S116331SyASilkissRZ2016Serum total IgG and IgG4 levels in thyroid eye disease9325328https://doi.org/10.2147/IMCRJ.S116331Search in Google Scholar
Takeshima K, Inaba H, Furukawa Y et al (2014) Elevated serum immunoglobulin G4 levels in patients with Graves’ disease and their clinical implications. Thyroid 24:736–743. https://doi.org/10.1089/thy.2013.0448TakeshimaKInabaHFurukawaY2014Elevated serum immunoglobulin G4 levels in patients with Graves’ disease and their clinical implications24736743https://doi.org/10.1089/thy.2013.0448Search in Google Scholar
Torimoto K, Okada Y, Kurozumi A et al (2017) Clinical features of patients with Basedow’s disease and high serum IgG4 levels. Intern Med 56:1009–1013. https://doi.org/10.2169/internalmedicine.56.7824TorimotoKOkadaYKurozumiA2017Clinical features of patients with Basedow’s disease and high serum IgG4 levels5610091013https://doi.org/10.2169/internalmedicine.56.7824Search in Google Scholar
Umehara H, Okazaki K, Kawa S et al (2021) The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol 31:529–533. https://doi.org/10.1080/14397595.2020.1859710UmeharaHOkazakiKKawaS2021The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD31529533https://doi.org/10.1080/14397595.2020.1859710Search in Google Scholar
Yamamoto M, Nishimoto N, Tabeya T et al (2012) [Usefulness of measuring serum IgG4 level as diagnostic and treatment marker in IgG4-related disease] (Article in Japanese). Nihon Rinsho Meneki Gakkai Kaishi 35:30–37. https://doi.org/10.2177/jsci.35.30YamamotoMNishimotoNTabeyaT2012[Usefulness of measuring serum IgG4 level as diagnostic and treatment marker in IgG4-related disease] (Article in Japanese)353037https://doi.org/10.2177/jsci.35.30Search in Google Scholar
Yu SH, Kang JG, Kim CS et al (2017) Clinical implications of immunoglobulin G4 to Graves’ ophthalmopathy. Thyroid 27:1185–1193. https://doi.org/10.1089/thy.2017.0126YuSHKangJGKimCS2017Clinical implications of immunoglobulin G4 to Graves’ ophthalmopathy2711851193https://doi.org/10.1089/thy.2017.0126Search in Google Scholar
Yu Y, Zhang J, Lu G et al (2016) Clinical relationship between IgG4-positive Hashimoto’s thyroiditis and papillary thyroid carcinoma. J Clin Endocrinol Metab 101:1516–1524. https://doi.org/10.1210/jc.2015-3783YuYZhangJLuG2016Clinical relationship between IgG4-positive Hashimoto’s thyroiditis and papillary thyroid carcinoma10115161524https://doi.org/10.1210/jc.2015-3783Search in Google Scholar